[site view] Rui Guozhong: the development trend of China's Biomedical Park

"China's biopharmaceutical parks have a long history Driven by national policies, market, capital and other favorable factors, the development of national biopharmaceutical parks (bases, Medicine Valley, science and technology fields, innovation demonstration zones) is in the ascendant National and provincial biomedical parks have become an important pillar of promoting regional and Chinese pharmaceutical economic development and a highland for innovation and entrepreneurship " Rui Guozhong, executive vice president of China Association of technology entrepreneurship and Secretary General of national biomedical park Alliance (CBCA), Ministry of science and technology, shared At present, there are two main types of Parks: high tech Zone and economic development zone It has been 30 years since the establishment of high-tech zones in 1988 Now, 168 high-tech zones are recognized by the state, while 219 are recognized by the State Economic Development Zone According to incomplete statistics, there are nearly 500 biomedical industrial parks at or above the provincial level in China, and it is estimated that the national parks will contribute nearly 50% of the national biomedical output in 2018 According to the trend of social and economic development in the past 40 years of national reform and opening up, the economic development zone may not be further developed in the future The important development is the high-tech zone, so many economic development zones are also in transformation and upgrading Now many high-tech zones and economic development zones are scattered and will be concentrated in the future Park is not only the main carrier of industry, but also the highland of innovation What kind of role do these parks play in national innovation? Throughout the world's successful biomedical parks, foreign countries, Europe and the United States, including Japan, which have done a good job in innovation, have built industrial clusters The industrial characteristics and competitive advantages of biomedical technology determine that the industrial cluster is the strategic choice for the construction and development of China's biomedical park, and the effect of China's biomedical industrial cluster has begun to appear In terms of biomedicine including biological health industry, China should be the country that started the concept and idea of industrial cluster earlier to promote the development of parks and industries The Ministry of science and technology put forward this idea as early as 2011 In 2012, the Ministry of science and technology formulated the innovation plan, implementation plan of innovative industrial cluster construction project (Trial), and identification and management of innovative industrial cluster pilot Administrative measures ", in 2013, the Ministry of science and technology started the identification of innovative industrial clusters in the high tech Zone, and by the end of 2017, 21 national level innovative industrial clusters of biomedicine had been identified Industrial cluster is not a simple gathering of enterprises, but based on specialized division of labor and social cooperation Large and medium-sized enterprises coexist and different types of enterprises coexist It is an ecological enterprise group Now, in order to promote the development of the park with high quality, the government must build it according to the idea of industrial cluster To cultivate and develop leading industries, characteristic industries and advantageous industries, and promote the formation of innovative industrial clusters, is not only an important means and carrier to cultivate strategic emerging industries, but also an important booster for the construction of an innovative country In the future, innovative ecology will play a leading role in promoting the high-quality development of parks The parks in China in the early days were mainly for the development of industries and the bearing of production and manufacturing functions They are all traditional industrial parks, sensitive to factor cost, and focus on building factor cost depressions In the future, the development of biopharmaceutical Park in China will transform from industrial cluster to innovative industrial ecology, which is sensitive to the system soft environment and focuses on optimizing the regional ecological environment Regional competition will be transformed from the competition of absorbing capital, technology and other elements into the competition of cultivating industrial resources, policies and other platforms, and further evolved into the ecological competition of gathering "seeds", cultivating "soil", making "platform" of excellence and spreading "sunshine and rain" Nowadays, many parks gather many elements Whether these resources are developing with high quality or not, they must have a good ecology, which can't live and die by itself This ecology symbolizes the overall high-quality development Therefore, in the future, especially the development of biomedical parks, it must be carried out according to the mode of integrating new urban areas with industries, allocating large resource platforms and conserving industrial ecosphere The development of CBCA alliance in the past decades has greatly promoted the economy and innovation, but there are still many problems in the development Thinking about these problems in the park, I published an article "Medicine Valley fever needs cold thinking" in China medicine daily 10 years ago, which mentioned some bottlenecks restricting the development of the park At present, there are still some similar problems, which need to be paid attention to by local governments, the state and various ministries and commissions They are the key points to be considered and solved in the next step, whether it is enterprises or parks, from the national level: 1 Repeated and blind construction, scattered resources, fierce regional vicious competition; 2 Industrial chain assimilation, unreasonable industrial structure, insufficient cluster effect and collaborative innovation; 3 Emphasize the scale of the park, ignore the "soft" environment, and the supporting service system of innovation and entrepreneurship is not perfect; 4 Lack of technological innovation ability, lack of compound talents, small industrial scale, and lack of competitiveness; 5 Insufficient capital investment and unreasonable financing structure In the face of these problems, it is proposed to build a park alliance to focus resources to solve the dilemma On September 29, 2016, at the "second national high tech Zone biomedical industry cluster Collaborative Innovation Conference" organized by the torch center of the Ministry of science and technology of Yantai high tech Zone, 17 national high tech zones established the "national biomedical park industry cluster Collaborative Innovation Alliance (CBCA)" The alliance is to solve the development of so many high-tech zones in China In fact, it is an innovative social organization, which is managed by the China Association for technology entrepreneurship under the Ministry of science and technology The positioning of the Ministry of science and technology for CBCA alliance is "co construction and sharing, win-win cooperation, strategic support and coordinated development" Strive to become an innovative industry cooperation organization with members of "one hundred parks and one thousand enterprises" in China's biomedical and health industry and a high-end platform for resource integration of the whole industry chain, and become a powerful "grab", "push" and "helper" to promote China's biomedical innovation and entrepreneurship and Park Innovation and development in the future After more than two years of development, the alliance has built a service system of five centers and one research institute, including innovation and transformation center, science and technology finance center, international cooperation center, market brand center, industrial incubation center, and Industrial Research Institute Around these six functional systems, we will take a look at the trend of industry reform, integrate high-end resources of the whole industry chain at home and abroad, serve the government, the region and the park, and work together to promote the innovation and high-quality development of China's biomedical industry At present, CBCA alliance is working on six aspects in combination with the annual plan: first, actively develop Park and enterprise members, and constantly expand the scale of the alliance CBCA has always been committed to building an innovative industrial organization with members of "one hundred parks and one thousand enterprises" in the field of biomedical industry in China It is hoped that in five years, two to three hundred parks that have done a good job in China will become members These parks include good enterprises in the industry It is hoped that all parks, including enterprises, can join the alliance family, build and share, and complete the glorious mission Second, implement the major project plan of the alliance and constantly innovate the working mechanism and mode In addition to strategic support, regional research is also needed for this industry The development of eastern and Western China is not balanced, so the alliance strengthened the construction of industrial research institutes and "think tanks", and completed the preparation of the Research Report on the development of biomedicine in national high tech Zone With the strong support of the torch center of the Ministry of science and technology, more than 10 industry tycoons have been organized to participate in the preparation for half a year, which is expected to be completed by October 2019, and the launching ceremony is planned to be held at the opening ceremony of the third annual conference of CBCA Alliance on October 17, 2019 Third, actively explore new opportunities and new models for international scientific and technological cooperation in medicine and health Such as actively promoting the construction of "China Australia Queensland torch medicine health innovation park" In November 2019, China EU International Cooperation mission on medicine and health science and technology was organized Fourth, vigorously promote the construction of Alliance Industrial incubation center, deepen regional cooperation, and promote the construction of alliance cooperation base (torch Guokang life and health science and Technology Industrial Park) Fifth, actively promote the construction of the "market brand center" of the alliance, hold the "top 100 high growth pharmaceutical enterprises in China biomedical park" selection at the third annual meeting of the alliance, and research and develop and release the "high quality development index system of China biomedical park" Hundreds of parks are classified according to 5A level and 3a level Sixthly, we will continue to hold the third annual meeting of CBCA in 2009, actively participate in other related activities, constantly expand the visibility and influence of the alliance, and build a platform for everyone to exchange and cooperate relying on the park Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.